GSA CAPITAL PARTNERS LLP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$595
-25.3%
11,845
-34.8%
0.05%
-48.5%
Q4 2022$796
-99.8%
18,168
+270.2%
0.10%
+94.1%
Q3 2021$505,000
-45.1%
4,908
-53.1%
0.05%
-51.0%
Q2 2021$920,000
+64.9%
10,463
+110.4%
0.10%
+14.3%
Q4 2020$558,000
+76.6%
4,973
+15.6%
0.09%
+111.6%
Q3 2019$316,0004,3010.04%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders